This version is not peer-reviewed.
Submitted:
26 April 2024
Posted:
26 April 2024
You are already at the latest version
A peer-reviewed article of this preprint also exists.
Variables | All (n=1087) |
IGRA positive (n=31, 2.8%) |
IGRA negative (n=1056, 97.2%) |
p |
---|---|---|---|---|
Sex, n (%) Female Male Other |
254 (23.4) 817 (75.2) 16 (1.5) |
9 (29.0) 22 (71.0) 0 |
245 (23.2) 795 (75.3) 16 (1.5) |
0.61 |
Country of origin, n (%) Italy Non-Italy-born |
892 (82.1) 195 (17.9) |
19 (61.3) 12 (38.7) |
873 (82.7) 183 (17.3) |
0.002 |
Age, median (IQR) | 49 (40-56) | 49 (35-57) | 48.5 (40-56) | 0.90 |
Drug users, n (%) No Yes Missing |
842 (77.5) 124 (11.4) 121 (11.1) |
22 (71.0) 5 (16.1) 4 (12.9) |
820 (77.6) 119 (11.3) 117 (11.1) |
0.64 |
MSM, n (%) No Yes Missing |
686 (63.1) 270 (24.8) 131 (12.1) |
18 (58.1) 8 (25.8) 5 (16.1) |
668 (63.3) 262 (24.8) 126 (11.9) |
0.75 |
Alcoholism, n (%) No Yes Missing |
619 (57.0) 45 (4.1) 423 (38.9) |
19 (61.3) 5 (16.1) 7 (22.6) |
600 (56.8) 40 (3.8) 416 (39.4) |
0.001 |
Years from HIV diagnosis, median (IQR) | 7.2 (2.3-17.3) | 5.0 (1.1-13.9) | 7.3 (2.3-17.3) | 0.34 |
CD4, median (IQR) | 618 (426-840) | 647 (460-802) | 617 (426-841) | 0.57 |
Nadir CD4, median (IQR) | 300 (104-484) | 406 (275-570) | 300 (103-482) | 0.06 |
Comorbidities, n (%) 0 1 ≥2 |
786 (72.3) 256 (23.6) 45 (4.1) |
26 (83.9) 3 (9.7) 2 (6.4) |
760 (72.0) 253 (24.0) 43 (4.1) |
0.16 |
Cardiovascular diseases, n (%) | 239 (22.0) | 4 (12.9) | 235 (22.2) | 0.27 |
Diabetes, n (%) | 61 (5.6) | 1 (3.2) | 60 (5.7) | 1.00 |
Solid neoplasia, n (%) | 40 (3.7) | 1 (3.2) | 39 (3.7) | 1.00 |
Hematologic malignancy, n (%) | 10 (0.9) | 1 (3.2) | 9 (0.8) | 0.25 |
Variables | All (n=26) |
Italy-born (n=14) |
Non-Italy-born (n=12) |
p |
---|---|---|---|---|
Pretreatment Ast Median IQR Alt Median IQR Bilirubin Median IQR |
18 (14-21) 18 (15-22) 0.40 (0.29-0.52) |
17 (14-19) 17 (15-21) 0.39 (0.29-0.50) |
22 (16-25) 18 (15-24) 0.52 (0.28-0.80) |
0.10 0.54 0.48 |
Last measured value* Ast Median IQR Alt Median IQR Bilirubin Median IQR |
21 (18-25) 22 (13-27) 0.41 (0.34-0.72) |
21 (18-29) 26 (15-30) 0.54 (0.33-0.72) |
21 (17-24) 17 (13-23) 0.39 (0.35-0.41) |
0.68 0.09 0.48 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
Altmetrics
Downloads
113
Views
56
Comments
0
Subscription
Notify me about updates to this article or when a peer-reviewed version is published.
© 2025 MDPI (Basel, Switzerland) unless otherwise stated